Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
1 other identifier
observational
600
1 country
1
Brief Summary
Although gains have been made in achieving the health-related Millennium Development Goals (MDG), much is still needed in countries affected by high levels of HIV/AIDS. Prevention of mother-to-child transmission (PMTCT) is a cornerstone strategy in reducing infant mortality from HIV. The study will employ a cluster randomized control trial (cRCT) with 26 health facilities randomized to two arms (intervention or control) to determine the effect of mobile phone technology on completion of key PMTCT milestones from antenatal to six weeks postpartum. The study will examine the acceptability, effectiveness, and cost of implementing a PMTCT-focused mHealth strategy among HIV-infected pregnant women, health workers, and male partners.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 18, 2012
CompletedFirst Posted
Study publicly available on registry
July 20, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedNovember 13, 2014
November 1, 2014
2.9 years
July 18, 2012
November 12, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The proportion of women who successfully complete key PMTCT transition points from antenatal to six weeks postpartum.
~ 6 months
Initiation of Infant prophylaxis, Facility delivery and receipt of results of 6 weeks early infant diagnosis by DNA PCR
~ 6 months
Secondary Outcomes (3)
Uptake ARV prophylaxis/ART during labor, delivery, and postpartum
~ 6 months
Self-reported maternal adherence to ARV prophylaxis/ART during pregnancy
~ 4 months
Time to initiation of ARV prophylaxis/ART uptake after initial identification of HIV seropositivity within ANC
~ 1 month
Study Arms (2)
Control
Intervention
Interventions
Health facilities where PMTCT services are available in the traditional clinical setting with HIV testing and counseling, PMTCT support, and enrollment in care and treatment.
In addition to the 'Standard of Care', HIV-infected pregnant women and male partners within the PMTCT program are engaged in multi-directional mobile communication for PMTCT promotion with health care providers.
Eligibility Criteria
Potential participants are recruited from participating study sites.
You may qualify if:
- HIV-positive pregnant women seeking ANC at a study site
- Up to 32 weeks gestation
- Own or have access to a mobile phone on which they can receive calls and SMS messages
You may not qualify if:
- HIV-positive pregnant women who have already initiated antiretroviral treatment
- Referral by pregnant female partner
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Elizabeth Glaser Pediatric AIDS Foundation
Nairobi, Kenya
Related Publications (1)
Kassaye SG, Ong'ech J, Sirengo M, Kose J, Matu L, McOdida P, Simiyu R, Syengo T, Muthama D, Machekano R. Cluster-Randomized Controlled Study of SMS Text Messages for Prevention of Mother-to-Child Transmission of HIV in Rural Kenya. AIDS Res Treat. 2016;2016:1289328. doi: 10.1155/2016/1289328. Epub 2016 Dec 8.
PMID: 28053784DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John Ong'ech, MBChB, MMed, MPH
Elizabeth Glaser Pediatric AIDS Foundation, UON/KNH
- PRINCIPAL INVESTIGATOR
Seble Kassaye, MD, MS
Elizabeth Glaser Pediatric AIDS Foundation
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2012
First Posted
July 20, 2012
Study Start
May 1, 2011
Primary Completion
April 1, 2014
Study Completion
April 1, 2014
Last Updated
November 13, 2014
Record last verified: 2014-11